Psychiatry & Neurology, Clinical Neurophysiology · Bronx, NY
NPI
1396972725
Since 2009
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
4256 Bronx Blvd Ste 5-6
Bronx, NY, 10466
Phone (929) 656-5243
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
5,192 services
Medicare patients, 2024
324
Average age 74
Drug cost, 2024
$3.3M
6,705 prescriptions
Company payments, 2025
$21K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farhad Kadkhodaei Elyaderani was code 99439 (chronic, principal, and transitional care management), 269 times for 37 patients. In total Farhad Kadkhodaei Elyaderani billed 5,192 services in 43 codes, and Medicare paid $173K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 269 | 37 | $43.38 | $12K |
| 95886 Electrical Nerve Conductivity | Office | 213 | 106 | $88.24 | $19K |
| 99214 Office E&M - Established | Office | 208 | 126 | $114.87 | $24K |
| 99213 Office E&M - Established | Office | 198 | 109 | $81.99 | $16K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 191 | 40 | $55.79 | $11K |
| 99204 Office E&M - New | Office | 116 | 116 | $150.79 | $17K |
| 99223 Hospital E&M - Initial | Facility | 93 | 91 | $154.35 | $14K |
| 95911 Electrical Nerve Conductivity | Office | 74 | 74 | $192.82 | $14K |
| 95912 Electrical Nerve Conductivity | Office | 38 | 38 | $224.31 | $8,524 |
| G0506 Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 27 | 27 | $55.22 | $1,491 |
| 93892 Ultrasound - Nonspecific | Office | 11 | 11 | $153.72 | $1,691 |
| 93890 Ultrasound - Nonspecific | Office | 11 | 11 | $211.87 | $2,331 |
| 93886 Ultrasound - Nonspecific | Office | 11 | 11 | $204.19 | $2,246 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 11 | 11 | $136.43 | $1,501 |
By year: 2022 $116K for 3,246 services; 2023 $137K for 4,124 services; 2024 $173K for 5,192 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farhad Kadkhodaei Elyaderani prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 664 prescriptions and refills. In total Farhad Kadkhodaei Elyaderani wrote 6,705 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 664 | 813 | 119 | $8,418 |
| Ubrelvy Ubrogepant | 481 | 489 | 131 | $723K |
| Qulipta Atogepant | 453 | 463 | 106 | $477K |
| Memantine Hcl Generic | 452 | 514 | 80 | $5,197 |
| Gabapentin Generic | 362 | 419 | 76 | $2,031 |
| Donepezil Hcl Generic | 327 | 419 | 64 | $1,963 |
| Ztlido Lidocaine | 267 | 285 | 84 | $265K |
| Meclizine Hcl Generic | 228 | 239 | 53 | $1,535 |
| Levetiracetam Generic | 217 | 252 | 31 | $2,649 |
| Nurtec Odt Rimegepant Sulfate | 170 | 176 | 40 | $288K |
| Quetiapine Fumarate Generic | 153 | 169 | 33 | $621 |
| Naproxen Generic | 152 | 154 | 40 | $1,523 |
| Emgality Pen Galcanezumab-Gnlm | 130 | 130 | 29 | $86K |
| Gocovri Amantadine Hcl | 128 | 136 | 17 | $229K |
| Aimovig Autoinjector Erenumab-Aooe | 126 | 129 | 20 | $91K |
Brand drugs: 2,523 claims; generic drugs: 4,143 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farhad Kadkhodaei Elyaderani $21K ($21K in general payments such as food, travel and fees) from 27 companies. The largest payer was Pfizer Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 59 | $16K |
| Alexion Pharmaceuticals, Inc. AZN | 13 | $1,388 |
| MDD US Operations, LLC | 23 | $485 |
| Axsome Therapeutics, Inc. AXSM | 19 | $365 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 27 | $342 |
| Scilex Pharmaceuticals Inc. | 25 | $341 |
| SK Life Science, Inc. | 22 | $321 |
| Amneal Pharmaceuticals LLC AMRX | 19 | $304 |
| ACADIA Pharmaceuticals Inc ACAD | 13 | $235 |
| Lilly USA, LLC LLY | 19 | $228 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.